|
Pine Labs Ltd
|
|
cosecy@pinelabs.com Website:www.pinelabs.com
|
|
Initial public offering of up to [*] equity shares of face value of Re. 1/- each ("Equity Shares") of Pine Labs Limited ("the Company" or "the Company") for cash at a price of Rs. [*] per equity share (including a Share Premium of Rs. [*] per Equity Share) ("Offer Price") aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1/- each aggregating up to Rs. 2080.00 crores by the company ("Fresh Issue") and an offer for sale of up to 82,348,779 equity shares of face value of Re. 1/- each aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders.
The company, in consultation with the brlms, may consider a pre-ipo placement of specified securities aggregating up to
Rs. 520.00 crores, as may be permitted under applicable law, prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. the pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken).
The offer includes a reservation of up to [*] equity shares of face value of Re. 1/- each, aggregating up to Rs. 2.5 crores (Constituting up to [*]% of the post-offer paid-up equity share capital), for subscription by eligible employees (As Defined Hereinafter) ("Employee Reservation Portion"). The company, in consultation with the brlms, may offer a discount of up to [*]% of the offer price to eligible employees bidding in the employee reservation portion ("Employee Discount"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*]% and [*]% of the post-offer paid-up equity share capital of the company, respectively.
Price Band: Rs. 210 to Rs. 221 per equity share of face value of Rs. 1 each.
The floor price is 210 times of the face value of the equity shares and the cap price is 221 times of the face value of the equity shares.
Bids can be made for a minimum of 67 equity shares and in multiples of 67 equity shares thereafter.
A discount of Rs. 21 per equity share is being offered ti eligible employees bidding in the employees reservation portion.
|
|
|
|
|
|
|
Pine Labs Ltd
|
| |
Rs Cr |
Lead Managers to the Issue |
| 0.00 |
| Citigroup Global Markets India Private Limited |
| J.P. Morgan India Private Limited |
| Jefferies India Private Limited |
| Morgan Stanley India Company Private Limited |
|
| 3809.32 |
|
| 114.83 |
|
| Rs.
210.00
|
|
|
|
|
|
| Projects |
|
Repayment / prepayment, in full or in part, of certain borrowings availed of by the Company
|
Investment in certain of our Subsidiaries, namely Qwikcilver Singapore, Pine Payment Solutions, Malaysia and Pine Labs UAE for expanding our presence outside India
|
|
Investment in IT assets, expenditure towards cloud infrastructure, technology development initiatives and procurement of DCPs,
|
General corporate purposes
|
|
Investment in IT assets and expenditure towards cloud infrastructure
|
Expenditure towards procurement of DCPs
|
|
Expenditure towards technology development initiatives
|
General corporate purposes and unidentified inorganic acquisitions
|
|
|
|
|
|